These guidelines, however, do not give a preference regarding which of the second-line agentswhich also include sulfonylureas (SU), dipeptidyl peptidase-4 inhibitors (DPP-IV), sodium-glucose cotransporter 2 inhibitors (SGLT-2i), insulin, thiazolidinediones (TZD) and acarboseshould be added to optimised metformin [13, 14]
If this is a concern, your clinician can discuss options
By engaging all three systems, Retatrutide creates a more comprehensive metabolic effect than any previous therapy
The recommended dose may range from 1 to 5 mL, depending on the concentration of each vitamin component and the desired therapeutic effect
The FDA recently approved another use for semaglutide, allowing it to help patients battling chronic weight management, but quite often these medications are not covered by insurance